The weekly litigation news digest is live. Subscribe now

IP Verse

Nanjing Luye Pharmaceutical competitive analysis

Latest patents of Nanjing Luye Pharmaceutical opposed by its competitors

Explore Nanjing Luye Pharmaceutical's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Dec 18, 2025
Patent NumberPublication DateTitleTotal Oppositions

Get instant alerts of patent oppositions faced by Nanjing Luye Pharmaceutical

EP3566696
Oct 7, 2020Risperidone Sustained Release Microsphere Composition1
EP3199146
Jul 17, 2019Risperidone Sustained Release Microsphere Composition2

Latest PTAB cases involving Nanjing Luye Pharmaceutical

Discover the latest PTAB cases involving Nanjing Luye Pharmaceutical, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Nanjing Luye Pharmaceutical with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Dec 18, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
NANJING LUYE PHARMACEUTICAL - 3 - -
AERA27 - - -
ALKERMES PHARMA IRELAND6912